Emory University as of Dec. 31, 2017
Portfolio Holdings for Emory University
Emory University holds 44 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Berkshire Hathaway (BRK.A) | 29.9 | $35M | 117.00 | 297598.29 | |
| Jd (JD) | 4.4 | $5.2M | 124k | 41.42 | |
| Fox News | 1.9 | $2.2M | 65k | 34.12 | |
| Wave Life Sciences (WVE) | 1.9 | $2.2M | 63k | 35.10 | |
| Armstrong World Industries (AWI) | 1.9 | $2.2M | 36k | 60.54 | |
| Genomic Health | 1.9 | $2.2M | 63k | 34.20 | |
| Beigene (BGNE) | 1.8 | $2.1M | 22k | 97.74 | |
| Alliance Data Systems Corporation (BFH) | 1.8 | $2.1M | 8.1k | 253.42 | |
| Trinity Industries (TRN) | 1.8 | $2.1M | 55k | 37.46 | |
| ACADIA Pharmaceuticals (ACAD) | 1.8 | $2.0M | 68k | 30.11 | |
| Ascendis Pharma A S (ASND) | 1.8 | $2.0M | 51k | 40.07 | |
| Avexis | 1.8 | $2.0M | 19k | 110.70 | |
| Dbv Technologies S A | 1.7 | $2.0M | 82k | 24.60 | |
| Alexion Pharmaceuticals | 1.7 | $2.0M | 17k | 119.60 | |
| Aquinox Pharmaceuticals | 1.7 | $2.0M | 170k | 11.76 | |
| Biohaven Pharmaceutical Holding | 1.7 | $2.0M | 74k | 26.98 | |
| Morgan Stanley (MS) | 1.7 | $2.0M | 38k | 52.46 | |
| KKR & Co | 1.7 | $2.0M | 94k | 21.06 | |
| BioMarin Pharmaceutical (BMRN) | 1.7 | $2.0M | 22k | 89.17 | |
| Seagate Technology Com Stk | 1.7 | $2.0M | 47k | 41.84 | |
| Zogenix | 1.7 | $2.0M | 49k | 40.05 | |
| Amicus Therapeutics (FOLD) | 1.7 | $1.9M | 135k | 14.39 | |
| Microsoft Corporation (MSFT) | 1.7 | $1.9M | 23k | 85.54 | |
| Neurocrine Biosciences (NBIX) | 1.7 | $1.9M | 25k | 77.57 | |
| BioCryst Pharmaceuticals (BCRX) | 1.6 | $1.9M | 384k | 4.91 | |
| Baker Hughes A Ge Company (BKR) | 1.6 | $1.9M | 59k | 31.65 | |
| Advanced Accelerat spon ads each rep 2 ord | 1.6 | $1.8M | 23k | 81.64 | |
| Cbre Group Inc Cl A (CBRE) | 1.6 | $1.8M | 42k | 43.32 | |
| Kala Pharmaceuticals | 1.6 | $1.8M | 99k | 18.49 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $1.8M | 14k | 127.02 | |
| Summit Midstream Partners | 1.5 | $1.8M | 88k | 20.50 | |
| Retrophin | 1.5 | $1.8M | 85k | 21.08 | |
| Global Blood Therapeutics In | 1.5 | $1.8M | 45k | 39.35 | |
| Seattle Genetics | 1.4 | $1.7M | 32k | 53.50 | |
| Tesaro | 1.4 | $1.7M | 20k | 82.86 | |
| Puma Biotechnology (PBYI) | 1.4 | $1.7M | 17k | 98.86 | |
| AVEO Pharmaceuticals | 1.4 | $1.7M | 603k | 2.79 | |
| La Jolla Pharmaceuticl Com Par | 1.4 | $1.7M | 52k | 32.19 | |
| Myovant Sciences | 1.4 | $1.7M | 131k | 12.64 | |
| Corium Intl | 1.4 | $1.6M | 168k | 9.61 | |
| Incyte Corporation (INCY) | 1.4 | $1.6M | 17k | 94.68 | |
| Achillion Pharmaceuticals | 1.3 | $1.5M | 518k | 2.88 | |
| Spdr S&p 500 Etf (SPY) | 0.2 | $237k | 889.00 | 266.59 | |
| Apple (AAPL) | 0.2 | $230k | 1.4k | 169.24 |
